Since the introduction of Patient-Controlled Analgesia(PCA)in China in 1994,the domain has witnessed its substantial advancements.The project,Clinical Research and Promotion of Postoperative Patient-Controlled Analgesia,achieved the Ministry of Education's Second Prize for Scientific and Technological Progress and the Chinese Medical Association's Third Prize in 2007.The innovation continued in 2011 with the development of an intelligent PCA system(Ai-PCA)endowed with Chinese independent patent rights and innovative digital medical technology.In 2019,the Key Technologies and Clinical Application of Intelligent Postoperative Patient-Controlled Analgesia Management was honored with the second-class Science and Technology Award by the Chinese Anti-Cancer Association.Furthering this trend.In 2023,the Standards and Promotion of Labor Analgesia in China secured the second-class prize in Medical Science and Technology from Huaxia Medical Science and Technology.This commentary suggest strategies for the qualitative enhancement of Ai-PCA and urge domestic scholars to spearhead the standardization of Ai-PCA.Expert Consensus on Clinical Application Standards for Patient-Controlled Analgesia leaded and edited by Pro.She has published,in 2024,which fervently supports the advancement of China's Ai-PCA technology towards a more intelligent future,to provide the public with higher quality and more comfortable pain management services.
关键词
数字医疗/智能镇痛/规范化/高质量发展
Key words
digital healthcare/intelligent patient-controlled analgesia/standardization/high-quality development
维普
万方数据